Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL705667 | 0.87 | ALDH1A1 (0.36) | ALDH1A1HPGD | |
| SCHEMBL5034146 | 0.82 | ACHE (0.47) | ACHETDP1ALDH1A1CA1CA2 | |
| SCHEMBL1798922 | 0.82 | ACHE (0.47) | ACHETDP1ALDH1A1CA1CA2 | |
| SCHEMBL801429 | 0.79 | — | — | |
| SCHEMBL10318540 | 0.79 | NR1H2 (0.41) | — | |
| SCHEMBL297883 | 0.79 | ACHE (0.50) | ACHETDP1ALDH1A1CA1CA2 | |
| SCHEMBL301896 | 0.79 | ACHE (0.50) | ACHETDP1ALDH1A1CA1CA2 | |
| SCHEMBL30965311 | 0.79 | ESR1 (0.44) | HPGD | |
| SCHEMBL1538600 | 0.79 | ACHE (0.50) | ACHETDP1ALDH1A1CA1CA2 | |
| SCHEMBL7913246 | 0.77 | LMNA (0.47) | ALDH1A1RAB9AKDM4ETSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103570874-A | Method for terminating copolymerization between conjugated diene and vinyl aromatic hydrocarbon | CHINA PETROLEUM & CHEMICAL | 2014-02-12 | — | — | CN | claimed |
| CN-103570851-A | Method for terminating conjugated diene homopolymerization | CHINA PETROLEUM & CHEMICAL | 2014-02-12 | — | — | CN | claimed |
| US-20250171469-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2025-05-29 | — | — | US | disclosed |
| US-12109812-B2 | Ink jet printing method and ink jet printing apparatus | SEIKO EPSON CORPORATION (JP) | 2024-10-08 | — | — | US | disclosed |
| EP-3743464-B1 | ORGANIC-INORGANIC AEROGEL COMPOSITES, METHODS AND USES THEREOF | BRONX CREATIVE&DESIGN CENTRE PTE LTD (SG) | 2024-03-06 | — | — | EP | disclosed |
| US-20230312616-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230312616-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230312616-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230250250-A1 | Organic-inorganic Aerogel Composites, Methods and Uses Thereof | BRONX CREATIVE & DESIGN CENTRE PTE LTD (SG) | 2023-08-10 | — | — | US | disclosed |
| CN-114055975-B | Ink jet recording method and ink jet recording apparatus | 精工爱普生株式会社 | 2023-05-12 | — | — | CN | disclosed |
| US-20220355262-A1 | SYSTEM AND METHOD FOR MANUFACTURING WATER-BASED HYDROPHOBIC AEROGELS AND AEROGEL COMPOSITES | KROSSLINKER PTE LTD (SG) | 2022-11-10 | — | — | US | disclosed |
| WO-2000040593-A2 | TARGET MOLECULE ATTACHMENT TO SURFACES | SURMODICS, INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| EP-0852340-A1 | SPACER FOR LIQUID CRYSTAL DISPLAY PANELS, METHOD OF MANUFACTURING THE SAME, AND LIQUID CRYSTAL DISPLAY PANEL | NIPPON SHOKUBAI KABUSHIKI KAISHA (JP) | 1998-07-08 | — | — | EP | disclosed |
| EP-0363584-B1 | Silylation method | GEN ELECTRIC (US) | 1994-09-14 | — | — | EP | disclosed |
| EP-0284873-B1 | SILYLATION METHOD | GENERAL ELECTRIC COMPANY (US) | 1993-09-01 | — | — | EP | disclosed |
| US-5082959-A | Oxidation of alkyl groups substituted on a trialkylsilyl-substituted aromatic ring using oxygen gas and a cobalt and/or manganese compound and a bromide as catalyts | AMOCO CORPORATION (US) | 1992-01-21 | — | — | US | disclosed |
| EP-0363584-A2 | Silylation method | GENERAL ELECTRIC COMPANY (US) | 1990-04-18 | — | — | EP | disclosed |
| US-4918197-A | CATALYTIC REACTION BETWEEN AROMATIC ACYLHALIDE AND HALOGENATED POLYSILANE | GENERAL ELECTRIC COMPANY (US) | 1990-04-17 | — | — | US | disclosed |
| EP-0284873-A2 | Silylation method | GENERAL ELECTRIC COMPANY (US) | 1988-10-05 | — | — | EP | disclosed |
| US-4709054-A | REACTION OF AROMATIC ACYL HALIDE AND HALOGENATED POLYSILANE, TRANSITION METAL CATALYST | GENERAL ELECTRIC COMPANY (US) | 1987-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312616-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1G, SCNN1B | ACHE 4850/4885TDP1 4655/4885ALDH1A1 3972/4885 |
| US-20250171469-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1G, SCNN1B | ACHE 4850/4885TDP1 4655/4885ALDH1A1 3972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.